sb 203580 has been researched along with Lupus Nephritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qiao-Ling, Z; Rong, T; Xiao-xia, Z; Xiao-Zhao, L; Zhi-Chun, L; Zhi-Qin, L | 1 |
1 other study(ies) available for sb 203580 and Lupus Nephritis
Article | Year |
---|---|
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Cells, Cultured; Chemokine CCL2; Female; Humans; Imidazoles; Interleukin-10; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; MAP Kinase Signaling System; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phytohemagglutinins; Pyridines; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; Tumor Necrosis Factors; TWEAK Receptor; Young Adult | 2012 |